Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy
Background: Several studies have demonstrated the antitumor activity of rosiglitazone (RGZ) in cancer cells, includ- ing breast cancer cells. However, the molecular targets of RGZ in the inhibition of angiogenesis in breast cancer cells remain unclear. This study aimed to explore the potential tar...
Saved in:
Main Authors: | Hermawan, Adam, Putri, Herwandhani |
---|---|
Format: | Article PeerReviewed |
Language: | English |
Published: |
Springer
2022
|
Subjects: | |
Online Access: | https://repository.ugm.ac.id/278720/1/Hermawan_FA.pdf https://repository.ugm.ac.id/278720/ https://bmcgenomdata.biomedcentral.com/articles/10.1186/s12863-022-01086-2 https://doi.org/10.1186/s12863-022-01086-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Universitas Gadjah Mada |
Language: | English |
Similar Items
-
Identification of potential target genes of honokiol in
overcoming breast cancer resistance to tamoxifen
by: Hermawan, Adam, et al.
Published: (2022) -
MDM2 is a Potential Target Gene of Glycyrrhizic Acid for Circumventing Breast Cancer Resistance to Tamoxifen: Integrative Bioinformatics Analysis
by: Azzahra, Salma Nur Azizah, et al.
Published: (2022) -
Antiangiogenic therapy in malignant glioma: Promise and challenge
by: Sith Sathornsumetee, et al.
Published: (2018) -
Functional network analysis of p85 and PI3K as potential gene targets and mechanism of oleanolic acid in overcoming breast cancer resistance to tamoxifen
by: Ibadurrahman, Wilfan, et al.
Published: (2022) -
Synthesis and evaluation of 1-(substituted)-3-prop-2-ynylureas as antiangiogenic agents
by: Kingkan Sanphanya, et al.
Published: (2018)